PLAINSBORO, N.J., Sept. 17, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the launch of the Selector SaberTip(TM) for the CUSA Selector(TM) ultrasonic surgical aspirator system, and will feature the Selector SaberTip(TM) at the 2007 Congress of Neurological Surgeons (CNS) annual meeting, September 15-20th, San Diego, California.
The new Selector SaberTip(TM) is designed for surgical applications requiring precise and controlled removal of bone and calcified tissues. The Selector SaberTip(TM) attaches to the CUSA Selector's 24 kHz neurosurgical short handpiece, offering surgeons market-leading bone-removal power and fine control, and significantly expanding the CUSA Selector system's surgical versatility and utility. Unique features include titanium nitride hardening, helical cutting action, and a central aspiration path, which assists in clearing debris from the operative field. The abrasive bone cutting portion of the Selector SaberTip(TM) covers half the outer circumference of the probe tip, allowing the surgeon to precisely remove bone without damaging adjacent critical structures.
"The SaberTip allows surgeons to remove bone without having to worry about catching soft tissue the way a drill can," said Dr. Jeffrey Arle, a neurosurgeon at The Lahey Clinic in Burlington, Massachusetts. "I like its precise bone cutting control. It has exciting potential in both cranial and spinal applications in my practice."
The Integra NeuroSciences sales organization will sell the Selector(TM) SaberTip. Integra NeuroSciences is a leading provider of implants, devices, instruments, and systems used in neurosurgery, neuromonitoring, neuro-trauma, and related critical care. Integra NeuroSciences' direct selling effort in the United States and Europe currently involves more than 150 sales professionals. In all other markets, Integra NeuroSciences products are sold through a network of distributors.
Integra LifeSciences Holdings Corporation, a world leader in regenerative medicine, is dedicated to improving the quality of life for patients through the development, manufacturing, and marketing of cost-effective surgical implants and medical instruments. Integra's products, used primarily in neurosurgery, extremity reconstruction, orthopedics and general surgery, are used to treat millions of patients every year. Integra's headquarters are in Plainsboro, New Jersey, and the company has research and manufacturing facilities throughout the world. For more information visit www.Integra-LS.com.
This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements concerning the future use of the Selector SaberTip(TM) and the CUSA Selector(TM) ultrasonic surgical aspirator system. Such forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from predicted or expected results. Among other things, the willingness of physicians to use these products may affect the prospects for their use in clinical procedures. In addition, the economic, competitive, governmental, technological and other factors, identified under the Risk Factors included in Item lA of Integra's Annual Report on Form 10-K for the year ended December 31, 2006, and information contained in subsequent filings with the Securities and Exchange Commission, could affect actual results.
IART-P